Medivis Announces $20 Million Series A Funding for Augmented Reality Surgery Project
The Series A funding is led by Thrive Capital.
Medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million Series A funding round led by Thrive Capital, with participation from Initialized Capital and Mayo Clinic. Additional investors include Bob Iger, Kevin Durant, Dr. Robert Spetzler, Hugo Barra and Coalition Operators.
Headquartered in New York City, Medivis has partnered with the nation's leading medical centers including MD Anderson Cancer Center, Providence Health, University of Pittsburgh Medical Center, Northwell Health and Cincinnati Children's Hospital. The company has also announced an expanded partnership with the Veterans Health Administration, the nation's largest integrated health system. The fundraise will be used to scale engineering, obtain regulatory clearances and globally commercialize across multiple specialties including neurosurgery, orthopedic surgery, interventional radiology and reconstructive surgery.
Continue reading this story here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
